QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

CUSIP: 74754R103

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
+113,603
SEC-reported price per share
$0.66
Number of holders
28
Value change
-$24,255
Number of buys
10
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
6,138,804

Security key

74754R103

Report period

Q1 2022

Institutions

28

Top holders

10

Ownership snapshot

Top reported holders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 19% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 19%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership Top 5
VANGUARD GROUP INC 19%
BlackRock Finance, Inc. 5.3%
GEODE CAPITAL MANAGEMENT, LLC 3.5%
PRICE T ROWE ASSOCIATES INC /MD/ 2.5%
STATE STREET CORP 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
19%
$1,251,000
1,168,972 shares
31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
5.3%
$347,000
325,043 shares
31 Dec 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
3.5%
$227,000
212,624 shares
31 Dec 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
2.5%
$166,000
154,700 shares
31 Dec 2021
STATE STREET CORP
13F
Company
13F
1.7%
$113,000
105,414 shares
31 Dec 2021
JPMORGAN CHASE & CO
13F
Company
13F
1.6%
$107,000
99,860 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
28
Shares
2,808,708
Rows available
28
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
25
Q1 2022 holders
28
Holder diff
3
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .